Stay updated on Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange Detected- The NCT02730546 study page now shows a 403 Forbidden page, replacing the previous study details. This prevents viewing the trial's overview, eligibility criteria, locations, and contacts.SummaryDifference25%

- Check55 days agoChange DetectedThe page's revision tag was incremented from v3.6.5 to v3.6.6, signaling a new version of the page.SummaryDifference0.0%

- Check77 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation/template. This change does not modify study content or settings.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now displays revision v3.6.4, replacing the previous v3.6.3. This indicates a minor document update and does not change the study details or participant information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.